PT Medikaloka Hermina Tbk (IDX:HEAL)
488.00
-4.00 (-0.81%)
Nov 20, 2026, 4:09 PM WIB
PT Medikaloka Hermina Tbk Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, PT Medikaloka Hermina Tbk stock has a consensus rating of "Buy" and an average price target of RpĀ 1,068. The average 1-year stock price forecast is 118.90% higher than the current stock price, while the lowest is RpĀ 570.00 (+16.80%) and the highest is RpĀ 1,730 (+254.51%).
Price Target: RpĀ 1,068 (+118.90%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PT Medikaloka Hermina Tbk stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 8 | 8 | 7 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 14 | 14 | 14 | 14 |
Financial Forecast
Revenue This Year
7.67T
from 7.13T
Increased by 7.47%
Revenue Next Year
8.40T
from 7.67T
Increased by 9.56%
EPS This Year
29.47
from 28.40
Increased by 3.78%
EPS Next Year
34.01
from 29.47
Increased by 15.39%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is IDR.